GSA Capital Partners LLP Acquires 39,085 Shares of Myomo, Inc. (NYSEAMERICAN:MYO)

GSA Capital Partners LLP increased its holdings in Myomo, Inc. (NYSEAMERICAN:MYO) by 60.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 103,342 shares of the company’s stock after buying an additional 39,085 shares during the period. GSA Capital Partners LLP owned 0.34% of Myomo worth $414,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Herr Investment Group LLC grew its position in Myomo by 72.9% in the 2nd quarter. Herr Investment Group LLC now owns 2,846,071 shares of the company’s stock worth $9,136,000 after purchasing an additional 1,200,244 shares in the last quarter. Rosalind Advisors Inc. grew its holdings in shares of Myomo by 13.4% during the 3rd quarter. Rosalind Advisors Inc. now owns 3,021,391 shares of the company’s stock valued at $12,116,000 after purchasing an additional 356,392 shares during the last quarter. Essex Investment Management Co. LLC grew its holdings in shares of Myomo by 40.2% during the 3rd quarter. Essex Investment Management Co. LLC now owns 899,135 shares of the company’s stock valued at $3,606,000 after purchasing an additional 257,749 shares during the last quarter. AIGH Capital Management LLC grew its holdings in shares of Myomo by 4.1% during the 2nd quarter. AIGH Capital Management LLC now owns 2,917,997 shares of the company’s stock valued at $9,367,000 after purchasing an additional 115,405 shares during the last quarter. Finally, AlphaCentric Advisors LLC bought a new stake in Myomo in the 3rd quarter worth $200,000. Institutional investors own 44.99% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on MYO shares. HC Wainwright reiterated a “buy” rating and set a $7.50 price target on shares of Myomo in a research report on Wednesday, November 13th. Ascendiant Capital Markets upped their target price on shares of Myomo from $8.50 to $9.00 and gave the stock a “buy” rating in a research note on Tuesday, November 12th. Finally, Craig Hallum initiated coverage on shares of Myomo in a research report on Wednesday, July 31st. They set a “buy” rating and a $7.00 price objective on the stock.

Myomo Stock Down 2.4 %

MYO stock opened at $4.80 on Friday. The company has a market capitalization of $145.20 million, a P/E ratio of -20.87 and a beta of 1.56. Myomo, Inc. has a 52 week low of $2.51 and a 52 week high of $5.64.

Myomo (NYSEAMERICAN:MYO) last announced its quarterly earnings data on Wednesday, November 6th. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.01. Myomo had a negative net margin of 33.22% and a negative return on equity of 86.30%. The business had revenue of $9.21 million during the quarter, compared to analysts’ expectations of $7.95 million. As a group, equities research analysts forecast that Myomo, Inc. will post -0.19 EPS for the current fiscal year.

Myomo Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.